Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma

Antonio Inserra, Claudio Alberto Mastronardi, Geraint Rogers, Julio Licinio, Ma Li Wong

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

56 Citas (Scopus)


Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and its incidence is expected to increase. Despite tremendous efforts to understand its underlying biological mechanisms, MDD pathophysiology remains elusive and pharmacotherapy outcomes are still far from ideal. Low-grade chronic inflammation seems to play a key role in mediating the interface between psychological stress, depressive symptomatology, altered intestinal microbiology, and MDD onset. We review the available pre-clinical and clinical evidence of an involvement of pro-inflammatory pathways in the pathogenesis, treatment, and remission of MDD. We focus on caspase 1, inducible nitric oxide synthase, and interferon gamma, three inflammatory systems dysregulated in MDD. Treatment strategies aiming at targeting such pathways alone or in combination with classical therapies could prove valuable in MDD. Further studies are needed to assess the safety and efficacy of immune modulation in MDD and other psychiatric disorders with neuroinflammatory components.

Idioma originalInglés estadounidense
Páginas (desde-hasta)4288-4305
Número de páginas18
PublicaciónMolecular Neurobiology
EstadoPublicada - jun. 1 2019

Áreas temáticas de ASJC Scopus

  • Neurología
  • Neurociencia celular y molecular


Profundice en los temas de investigación de 'Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma'. En conjunto forman una huella única.

Citar esto